US Patent Issued to Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Eberhard Karls Universitat Tubingen on Aug. 26 for "PSMA binding antibody and uses thereof" (German Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,208, issued on Aug. 26, was assigned to Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (Heidelberg, Germany) and Eberhard Karls Universitat Tubingen (Tubingen, Germany).

"PSMA binding antibody and uses thereof" was invented by Helmut Salih (Stuttgart, Germany), Fabian Vogt (Tubingen, Germany), Gundram Jung (Rottenburg, Germany) and Latifa Zekri-Metref (Tubingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel PSMA binding antibody termed 10B3 and pharmaceutical and diagnostic uses of the antibody 10B3. The PSMA antibody 10B3 does not cross-compete with the state of the art PMSA binding...